Contact this trialFirst, we need to learn more about you.
Dietary Supplement
Montbretin A for Type 2 Diabetes
Recruiting1 awardPhase 1
Vancouver, British Columbia
This trial tests Montbretin A (MbA) in people with type 2 diabetes to see if it is safe and has fewer side effects than current treatments. MbA aims to control blood sugar by blocking a specific process in the body, reducing sugar absorption and sudden increases in blood sugar levels. Participants will take increasing doses of MbA over a short period and undergo various tests to monitor its effects.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service